A risk score model based on four genes (GRID2, ATG4D, GABARAPL2, and CXCR4) was identified as a potential prognostic biomarker for OS of GC (AUC, 0.671; Qiu et al., 2020). This evidence concerns the gene GABARAPL2 and gastric cancer.